A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment

These findings suggest that FA-Cur-NPs are a promising approach for improving cancer therapy through active targeting and controllable release.